Literature DB >> 30510863

Simultaneous Bilateral Optic Neuritis Following Human Papillomavirus Vaccination in a Young Child.

Ngu Dau Bing Michael1, Tengku Norina Tuan Jaffar2, Adil Hussein3, Wan-Hazabbah Wan Hitam1.   

Abstract

Vaccination-induced optic neuritis is not common. The development of optic neuritis following various vaccinations have been reported, suggesting a possible association between optic neuritis and vaccination. Of those reported cases, influenza vaccines have been the most common. Although rare, those patients who developed optic neuritis following HPV vaccination also presented with other central nervous system (CNS) demyelinating syndromes, especially following a booster dose. We present a rare case of simultaneous isolated bilateral optic neuritis following the first dose of an HPV vaccination in a young child. She received treatment with a systemic corticosteroid that resulted in a good clinical outcome without developing any demyelinating disease.

Entities:  

Keywords:  human papillomavirus; optic neuritis; vaccination

Year:  2018        PMID: 30510863      PMCID: PMC6257468          DOI: 10.7759/cureus.3352

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  11 in total

1.  The optic neuritis treatment trial: a definitive answer and profound impact with unexpected results.

Authors:  Nicholas J Volpe
Journal:  Arch Ophthalmol       Date:  2008-07

2.  CNS demyelination and quadrivalent HPV vaccination.

Authors:  I Sutton; R Lahoria; Il Tan; P Clouston; Mh Barnett
Journal:  Mult Scler       Date:  2008-09-19       Impact factor: 6.312

Review 3.  A literature review on optic neuritis following vaccination against virus infections.

Authors:  Joerg-Patrick Stübgen
Journal:  Autoimmun Rev       Date:  2013-03-27       Impact factor: 9.754

4.  A 16-year-old girl with bilateral visual loss and left hemiparesis following an immunization against human papilloma virus.

Authors:  Francis J DiMario; Mirna Hajjar; Thomas Ciesielski
Journal:  J Child Neurol       Date:  2010-03       Impact factor: 1.987

Review 5.  Optic neuritis: a review.

Authors:  P N Shams; G T Plant
Journal:  Int MS J       Date:  2009-09

6.  A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.

Authors:  R W Beck; P A Cleary; M M Anderson; J L Keltner; W T Shults; D I Kaufman; E G Buckley; J J Corbett; M J Kupersmith; N R Miller
Journal:  N Engl J Med       Date:  1992-02-27       Impact factor: 91.245

Review 7.  The spectrum of post-vaccination inflammatory CNS demyelinating syndromes.

Authors:  Dimitrios Karussis; Panayiota Petrou
Journal:  Autoimmun Rev       Date:  2014-03       Impact factor: 9.754

Review 8.  Optic neuritis in pediatric population: a review in current tendencies of diagnosis and management.

Authors:  Rafael José Pérez-Cambrodí; Aránzazu Gómez-Hurtado Cubillana; María L Merino-Suárez; David P Piñero-Llorens; Carlos Laria-Ochaita
Journal:  J Optom       Date:  2014-02-18

9.  Recurrent optic neuritis and neuromyelitis optica-IgG following first and second human papillomavirus vaccinations.

Authors:  Hyeyeon Chang; Hye Lim Lee; Minju Yeo; Ji Seon Kim; Dong-Ick Shin; Sang-Soo Lee; Sung-Hyun Lee
Journal:  Clin Neurol Neurosurg       Date:  2016-03-29       Impact factor: 1.876

Review 10.  Safety of human papillomavirus vaccines: a review.

Authors:  Michela Stillo; Paloma Carrillo Santisteve; Pier Luigi Lopalco
Journal:  Expert Opin Drug Saf       Date:  2015-02-18       Impact factor: 4.250

View more
  2 in total

1.  Neuroretinitis after the second injection of a SARS-CoV-2-vaccine: A case report.

Authors:  Chaeyeon Lee; Kyung-Ah Park; Don-Il Ham; Minjung Seong; Hyung-Jin Kim; Ga-In Lee; Sei Yeul Oh
Journal:  Am J Ophthalmol Case Rep       Date:  2022-05-25

2.  Optic neuritis following COVID-19 vaccination: Coincidence or side-effect? - A case series.

Authors:  Madhurima Roy; Anuradha Chandra; Sangeeta Roy; Charuta Shrotriya
Journal:  Indian J Ophthalmol       Date:  2022-02       Impact factor: 2.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.